A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)

Clinical trial NCT04055454 · COMPLETED

Trial details

NCT number: NCT04055454
Sponsor: Themis Bioscience GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lassa Virus Infection

Start date: 2019-09-26
Primary completion: 2020-03-13
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.